Tag: subterra

CanniMed Therapeutics (TSX: CMED) Prices IPO at $12

CanniMed Therapeutics (TSX: CMED) priced its initial public offering at $12, selling 5mm shares through a syndicate led by AltaCorp Capital to raise $60mm. The underwriters, which also included Canaccord...
- December 21st, 2016 at 6:57 pm

Canadian Cannabis Producer CanniMed Prepares for IPO

The list of Canadian licensed producers (LPs) of cannabis expecting to go public just got longer. CanniMed Therapeutics, the parent of CanniMed Ltd. and Prairie Plant Systems, issued a press...
- November 28th, 2016 at 1:56 pm